The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial of enzalutamide plus the glucocorticoid receptor antagonist mifepristone for patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Russell Zelig Szmulewitz
Consulting or Advisory Role - Abbvie; Pfizer
Research Funding - Astellas Pharma (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); Macrogenics (Inst)
Patents, Royalties, Other Intellectual Property - Corcept Therapeutics (Inst); Patent
 
Chadi Nabhan
Consulting or Advisory Role - Cardinal Health; Celgene; Genentech; Medivation
Research Funding - Celgene; Genentech; Medivation
 
Peter H. O'Donnell
Stock and Other Ownership Interests - Davita
Honoraria - Algeta ASA; American Medical Forum; Dendreon; Genentech/Roche; Novartis; OptumHealth
Research Funding - Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - Named as co-inventor on a pending patent for a genomic prescribing system for medication prescribing.
Travel, Accommodations, Expenses - Sequenom
Other Relationship - Advance Medical
 
Jacob Kach
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Elia Martinez
No Relationships to Disclose
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Johnson & Johnson; medpacto; Merck; Sotio
Consulting or Advisory Role - Bayer; CVS Caremark; Johnson & Johnson; medpacto; Merck; Sotio
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Other Relationship - UpToDate